2,3-dihydroxybenzoic acid-containing nanofiber wound dressings inhibit biofilm formation by Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 4, 2014, Pages 2098-2104

  Ahire, Jayesh J ^a   Dicks, Leon M T ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDROXYBENZOIC ACID; IRON CHELATING AGENT; MACROGOL; NANOFIBER; POLYLACTIDE;

ARTICLE; BIOFILM; CELL COUNT; CELL GROWTH; COLONY FORMING UNIT; CONNECTIVE TISSUE; CONTROLLED STUDY; ELECTROSPINNING; GROWTH INHIBITION; LIPID PEROXIDATION; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; WOUND DRESSING; WOUND HEALING;

ANTI-BACTERIAL AGENTS; BIOFILMS; HYDROXYBENZOATES; MICROBIAL SENSITIVITY TESTS; NANOFIBERS; PSEUDOMONAS AERUGINOSA;

EID: 84896927140     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02397-13     Document Type: Article

References (30)

1. Harjai K, Bala A, Gupta RK, Sharma R. 2013. Leaf extract of Azadirachta indica (neem): a potential antibiofilm agent for Pseudomonas aeruginosa. Pathog. Dis. 69:62-65. http://dx.doi.org/10.1111/2049-632X.12050.
2. Ehrlich GD, Veeh R, Wang X, Costerton JW, Hayes JD, Hu FZ, Daigle BJ, Ehrlich MD, Post JC. 2002. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA 287:1710-1715. http://dx.doi.org/10. 1001/jama.287.13.1710. (Pubitemid 34289224)
3. Cross A, Allen JR, Burke J, Ducel G, Harris A, John J, Johnson D, Lew M, MacMillan B, Meers P, Skalova R, Wenzel R, Tenney J. 1983. Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Rev. Infec. Dis. 5(Suppl 5):S837-S845. http://dx.doi.org/10.1093/clinids/5.Supplement-5.S837.
4. Mulcahy LR, Isabella VM, Lewis K. 6 October 2013. Pseudomonas aeruginosa biofilms in disease. Microb. Ecol. http://dx.doi.org/10.1007/s00248-013-0297-x.
5. Trøstrup H, Thomsen K, Christophersen LJ, Hougen HP, Bjarnsholt T, Jensen PØ, Kirkby N, Calum H, Høiby N, Moser C. 2013. Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB/c mice in a novel chronic wound model. Wound Repair Regen. 21:292-299. http://dx.doi.org/10. 1111/wrr.12016.
6. Zhao T, Liu Y. 2010. N-acetylcysteine inhibits biofilms produced by Pseudomonas aeruginosa. BMC Microbiol. 10:140. http://dx.doi.org/10.1186/1471- 2180-10-140.
7. Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM. 2003. A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol. Surg. 29:631-635. http://dx.doi.org/10.1046/j.1524-4725.2003.29146.x. (Pubitemid 36702450)
8. Poole K. 2001. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J. Mol. Microbiol. Biotechnol. 3:255-264.
9. Folsom JP, Richards L, Pitts B, Roe F, Ehrlich GD, Parker A, Mazurie A, Stewart PS. 2010. Physiology of Pseudomonas aeruginosa in biofilms as revealed by transcriptome analysis. BMC Microbiol. 10:294. http://dx.doi.org/10.1186/ 1471-2180-10-294.
10. Gellatly SL, Hancock RE. 2013. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog. Dis. 67:159-173. http://dx.doi.org/10. 1111/2049-632X.12033.
11. Zhao K, Tseng BS, Beckerman B, Jin F, Gibiansky ML, Harrison JJ, Luijten E, Parsek MR, Wong GC. 2013. Psl trails guide exploration and microcolony formation in Pseudomonas aeruginosa biofilms. Nature 497:388-391. http://dx.doi.org/10.1038/nature12155.
12. Singh PK, Parsek MR, Greenberg EP, Welsh MJ. 2002. A component of innate immunity prevents bacterial biofilm development. Nature 417:552-555. http://dx.doi.org/10.1038/417552a. (Pubitemid 34595922)
13. Banin E, Vasil ML, Greenberg EP. 2005. Iron and Pseudomonas aeruginosa biofilm formation. Proc. Natl. Acad. Sci. U. S. A. 102:11076-11081. http://dx.doi.org/10.1073/pnas.0504266102. (Pubitemid 41105995)
14. Burns JL, Mancoll JS, Phillips LG. 2003. Impairments to wound healing. Clin. Plast. Surg. 30:47-56. http://dx.doi.org/10.1016/S0094-1298(02)00074-3. (Pubitemid 36288300)
15. Kamiya H, Ehara T, Matsumoto T. 2012. Inhibitory effects of lactoferrin on biofilm formation in clinical isolates of Pseudomonas aeruginosa. J. Infect. Chemother. 18:47-52. http://dx.doi.org/10.1007/s10156-011-0287-1.
16. O'May CY, Sanderson K, Roddam LF, Kirov SM, Reid DW. 2009. Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions. J. Med. Microbiol. 58(Pt 6):765-773. http://dx.doi.org/10. 1099/jmm.0.004416-0.
17. Graziano JH, Miller DR, Grady RW, Cerami A. 1976. Inhibition of membrane peroxidation in thalassaemic erythrocytes by 2,3-dihydroxybenzoic acid. Br. J. Haematol. 32:351-356. http://dx.doi.org/10.1111/j.1365-2141.1976.tb00938.x.
18. Blatt J, Taylor SR, Kontoghiorghes GJ. 1989. Comparison of activity of deferoxamine with that of oral iron chelators against human neuroblastoma cell lines. Cancer Res. 49:2925-2927. (Pubitemid 19148627)
19. Grootveld M, Halliwell B. 1988. 2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism. Biochem. Pharmacol. 37:271-280. http://dx.doi.org/10. 1016/0006-2952(88)90729-0. (Pubitemid 18039708)
20. Sousa M, Ousingsawat J, Seitz R, Puntheeranurak S, Regalado A, Schmidt A, Grego T, Jansakul C, Amaral MD, Schreiber R, Kunzelmann K. 2007. An extract from the medicinal plant Phyllanthus acidus and its isolated compounds induce airway chloride secretion: a potential treatment for cystic fibrosis. Mol. Pharmacol. 71:366-376. http://dx.doi.org/10.1124/mol.106.025262. (Pubitemid 46021006)
21. Neilands JB. 1995. Siderophores: structure and function of microbial iron transport compounds. J. Biol. Chem. 270:26723-26726.
22. Heunis TD, Smith C, Dicks LMT. 2013. Evaluation of a nisin-eluting nanofiber scaffold to treat Staphylococcus aureus-induced skin infections in mice. Antimicrob. Agents Chemother. 57:3928-3935. http://dx.doi.org/10.1128/AAC. 00622-13.
23. Payne SM. 1994. Detection, isolation, and characterization of siderophores. Methods Enzymol. 235:329-344. (Pubitemid 24191448)
24. O'Toole GA. 2011. Microtiter dish biofilm formation assay. J. Vis. Exp. (47):pii=2437. http://dx.doi.org/10.3791/2437.
25. Liu H, Ding X, Zhou G, Li P, Wei X, Fan Y. 2013. Electrospinning of nanofibers for tissue engineering applications. J. Nanomaterials 2013:1-11. http://dx.doi.org/10.1155/2013/495708.
26. Tan S, Huang X, Wu B. 2007. Some fascinating phenomena in electro-spinning processes and applications of electrospun nanofibers. Polym. Int. 56:1330-1339. http://dx.doi.org/10.1002/pi.2354. (Pubitemid 47593181)
27. Balasubramanian D, Schneper L, Kumari H, Mathee K. 2013. A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res. 41:1-20. http://dx.doi.org/10.1093/nar/gks1039.
28. Bullen JJ, Rogers HJ, Griffiths E. 1978. Role of iron in bacterial infection. Curr. Top. Microbiol. Immunol. 80:1-35.
29. Lin MH, Chang FR, Hua MY, Wu YC, Liu ST. 2011. Inhibitory effects of 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose on biofilm formation by Staphylococcus aureus. Antimicrob. Agents Chemother. 55:1021-1027. http://dx.doi.org/10.1128/AAC.00843-10.
30. Li S, Crooks PA, Wei X, de Leon J. 2004. Toxicity of dipyridyl compounds and related compounds. Criti. Rev. Toxicol. 34:447-460. http://dx.doi.org/10. 1080/10408440490503143.